Atea Pharmaceuticals
AVIR
#7561
Rank
C$0.38 B
Marketcap
$4.54
Share price
2.85%
Change (1 day)
15.57%
Change (1 year)

Earnings for Atea Pharmaceuticals (AVIR)

Earnings in 2024 (TTM): -C$0.24 Billion

According to Atea Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$0.19 Billion a decrease over its 2022 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atea Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.24 Billion25.4%
2023 -C$0.19 Billion12.92%
2022 -C$0.17 Billion-186.22%
2021 C$0.19 B-1366.01%
2020 -C$15.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.18 Billion-28.49%๐Ÿ‡บ๐Ÿ‡ธ USA